通过ferroptosis介导的线粒体功能障碍引起的Trastuzumab诱导的心肌病变
Ting Ye1, Wei Yang2, Tielei Gao3
1Department of Pathophysiology, Harbin Medical University, 157 Baojian Road, Nangang District, Harbin, 150081, China.
Free radical biology & medicine
|July 1, 2023
概括
特拉斯图祖马布 (TRZ) 通过诱导铁亡,一种涉及铁和脂质代谢的细胞死亡形式,引起心脏损伤. 抑制铁亡可能会保护心脏免受TRZ诱导的心脏毒性.
科学领域:
- 生物化学 生物化学
- 心脏病学 心脏病学
- 在瘤学瘤学.
背景情况:
- 特拉斯图祖马布 (TRZ) 是治疗HER-2-阳性乳腺癌的重要疗法.
- 特拉斯图祖马布诱导的心脏毒性 (TIC) 限制了其临床应用.
- 人们还没有完全理解TIC的分子机制.
研究的目的:
- 为了研究铁化在TIC中的作用.
- 阐明将TRZ与线粒体功能障碍和铁亡联系起来的分子途径.
主要方法:
- 建立了TIC的体内 (小鼠) 和体外 (心肌细胞) 模型.
- 评估心脏功能,使用心声回声和细胞活力测试.
- 分析了涉及铁和线粒体功能的关键蛋白质和代谢物 (GPx4,4-HNE,MDA,VDAC1,mPTP,MMP,ATP,GSH/GSSG,铁).
- 利用铁酶抑制剂 (Fer-1,DFO) 和基因过度表达 (mitoGPx4) 来评估治疗潜力.
主要成果:
- 通过抑制ErbB2/PI3K/AKT/Nrf2通路,TRZ降低了GPx4和增加了脂质过氧化 (4-HNE,MDA).
- 线粒体4-HNE积累导致VDAC1寡合化,mPTP开放,并降低了MMP和ATP水平.
- TRZ破坏了线粒体的氧化还原平衡和铁的平衡.
- 铁灭菌抑制剂和mitoGPx4过度表达改善了TIC和铁灭菌.
结论:
- 铁酶介导的线粒体功能障碍是TIC背后的一个关键机制.
- 向铁亡途径提供了一个有前途的心脏保护策略,防止TRZ治疗.
相关概念视频
Electron Transport Chain: Complex I and II
14.6K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
14.6K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
16
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Cardiomyopathy IV: Restrictive Cardiomyopathy
12
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12
Necrosis
4.6K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.6K
Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Cardiomyopathy I: Introduction and Classification
19
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
19


